1 of 1
Story summary
- A study published in JAMA Network Open found that glucagon-like peptide-1 (GLP-1) weight-loss drugs reduced severe asthma attacks in overweight teens.
- Researchers tracked 1,070 adolescents aged 12 to 18 with asthma.
- Teens on GLP-1 medications had eight ER visits.
- Teens not on GLP-1 medications had 19 ER visits.
- The study suggests weight loss from these medications may reduce obesity-related inflammation and ease asthma symptoms.
